2) CD32b expression on memory B cells—which are also considered to be critical for CIDP and its treatment with IVIg (Tackenberg et al. 2009)—was not altered. This evidence concerns the gene FCGR2B and chronic inflammatory demyelinating polyradiculoneuropathy.